Browse > Article
http://dx.doi.org/10.22246/jikm.2019.40.4.723

A Case of Long-term Survival with Traditional Korean Medicine Alone for Recurrent Metastases of Colorectal Cancer  

Kim, Eun-hye (Dept. of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Yoon, Sung-soo (Dept. of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Lee, Jee-young (Dept. of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Yoon, Seong-woo (Dept. of Korean Internal Medicine, Korean Medicine Cancer Center, Kyung Hee University Hospital at Gangdong)
Publication Information
The Journal of Internal Korean Medicine / v.40, no.4, 2019 , pp. 723-729 More about this Journal
Abstract
Objective: This study was aimed at reporting on a patient with repeated recurrence of metastatic colorectal cancer treated with traditional Korean medicine (TKM) alone after operation and chemotherapy. Method: The patient with metastatic colorectal cancer received tumor resections four times and perioperative chemotherapy for repeated recurrence from February 2013 until March 2015. TKM, which included Gunchil-dan and Haeam-dan, was administered until June 2019 to prevent additional relapses. Results: After 49 months of TKM treatment, there was no tumor recurrence. A no evidence of disease (NED) state was maintained from March 2015 to June 2019. Recurrence-free survival (RFS) was shown for 49 months and overall survival (OS) for 78 months. Serious adverse events evaluated according to the Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 were not identified. This study suggested that TKM with herbal medicine including aRVS might prolong survival and inhibit recurrence of tumors in patients with metastatic colorectal cancer.
Keywords
colorectal cancer; recurrence; Gunchil-dan; Haeam-dan; traditional Korean medicine; herbal medicine;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 McCulloch M, Ly H, Broffman M, See C, Clemons J, Chang R. Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer: A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials. Integr Cancer Ther 201;15(3):285-307.   DOI
2 Kim JH, Go HY, Jin DH, Kim HP, Hong MH, Chung WY, et al. Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Lett 2008;265(2):197-205.   DOI
3 Choi WC, An SM, Kwon EM, Eo WK, Lee SH. Impact of Standardized Allergen-Removed Rhus verniciflua Stokes Extract on Advanced Adenocarcinoma of the Ampulla of Vater: A Case Series. Evid Based Complement Alternat Med 2013;2013.
4 Lee SH, Choi WC, Yoon SW. Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience. Integr Cancer Ther 2009;8(2):148-52.   DOI
5 Lee JY, Oh HK, Ryu HS, Kim NJ, Jung WY, Oh HA, et al. Anti-tumor Activities of Haeamdan on Various Cancer Cells. J of Kor Traditional Oncology 2015;20(2):5-11.   DOI
6 The Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2016, Ministry of Health and Welfare, 2019.
7 Carpizo DR, Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Ann Surg Oncol 2009;16(9):2411-21.   DOI
8 National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Colon cancer. Version 2. 2019. Available from: http/www.nccn.org/
9 Leung U, Gonen M, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, et al. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. Ann Surg 2017;265(1):158-65.   DOI
10 McCulloch M, Ly H, Broffman M, See C, Clemons J, Chang R. Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer: A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials. Integr Cancer Ther 201;15(3):285-307.   DOI
11 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mcfadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American journal of clinical oncology 1982;5(6):649-56.   DOI
12 Zhai XF, Liu XL, Shen F, Fan J, Ling CQ. Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study. Cancer 2018;124(10):2161-8.   DOI
13 Kang YH, Hong MN, Han CW, Choi JY, Park SH, Kim SY. Review on Clinical Studies of Traditional Herbal Medicine and Acupuncture Treatments for Colorectal Cancer Patients. J Physiol & Pathol Korean Med 2016;30(4):219-28.   DOI
14 Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th Edition. New York: Springer International Publishing; 2017.
15 National Cancer Insitute. Common Terminology Criteria for Adverse Events, Version 5.0, revised March, 2018. Avaliable from:URL:https://ctep.cancer.gov/protocoldevelopment/electronic_applications /docs/CTCAE_v5_Quick_Reference_8.5x11.pdf
16 Leung U, Gonen M, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, et al. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. Ann Surg 2017;265(1):158-65.   DOI
17 Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013;14(12):1208-15.   DOI